⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20543354 | 0.85 | LPAR3 (0.38) | — | |
| SCHEMBL28709352 | 0.85 | — | — | |
| SCHEMBL4934857 | 0.83 | CYP3A4 (0.56) | — | |
| Ammonia Solution, Strong SCHEMBL28732230 | 0.83 | CYP3A4 (0.56) | — | |
| SCHEMBL2459739 | 0.83 | LPAR3 (0.65) | — | |
| Ammonia Solution, Strong SCHEMBL28166074 | 0.83 | CYP3A4 (0.56) | — | |
| SCHEMBL1008814 | 0.83 | LPAR3 (0.33) | — | |
| SCHEMBL2712213 | 0.81 | LPAR3 (0.69) | — | |
| Hydrogen Sulfide SCHEMBL3875769 | 0.81 | LPAR3 (0.63) | — | |
| Iodide SCHEMBL3909272 | 0.81 | LPAR3 (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109078655-A | A kind of Pd-IL/Al of high dispersive2O3The preparation of catalyst and its application in acetylene selective hydrogenation reaction | 浙江工业大学 | 2018-12-25 | — | — | CN | claimed |
| EP-0136375-A1 | A regulatory glycoprotein for immune response in the production of T-cell growth factor | SHANKSVILLE CORPORATION N.V. (AN) | 1985-04-10 | — | — | EP | claimed |
| WO-2024073802-A1 | METHOD OF DETECTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-04-11 | — | — | WO | disclosed |
| EP-4314774-A1 | METHOD OF DETECTION | The University of Queensland (AU) | 2024-02-07 | — | — | EP | disclosed |
| US-20230321281-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | FTGEN Corp | 2023-10-12 | — | — | US | disclosed |
| CN-116615552-A | Compositions and methods for treating ocular disorders | 方拓生物科技公司 | 2023-08-18 | — | — | CN | disclosed |
| EP-4185319-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | Frontera Therapeutics, Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| US-20220231338-A1 | Nonaqueous Electrolytic Solution | CENTRAL GLASS CO., LTD. (JP) | 2022-07-21 | — | — | US | disclosed |
| CN-114728992-A | Method for producing phosphate compound | 斯泰拉化工公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2021189112-A1 | METHOD OF DETECTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2021-09-30 | — | — | WO | disclosed |
| CN-106848406-B | Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2020-09-11 | — | — | CN | disclosed |
| CN-105633345-B | Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2020-01-17 | — | — | CN | disclosed |
| CN-104822676-B | Novel ROCK inhibitors | PH制药有限公司 | 2019-11-05 | — | — | CN | disclosed |
| CN-110151979-A | Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof | 奥拉姆德有限公司 | 2019-08-23 | — | — | CN | disclosed |
| US-10141607-B2 | Nonaqueous electrolyte secondary battery | GS YUASA INTERNATIONAL LTD. (JP) | 2018-11-27 | — | — | US | disclosed |
| US-20170077550-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | GS YUASA INTERNATIONAL LTD. (JP) | 2017-03-16 | — | — | US | disclosed |
| EP-0567431-A1 | Apparatus for removing components from solutions | CIBA-GEIGY AG (CH) | 1993-10-27 | — | — | EP | disclosed |
| WO-1993003748-A1 | MODULATION OF BLOOD PRESSURE AND INHIBITION OF PLATELET ACTIVATION WITH KININOGEN FRAGMENT | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1993-03-04 | — | — | WO | disclosed |